Statement re. Suspension
September 02 2009 - 2:00AM
UK Regulatory
TIDMICX
RNS Number : 3536Y
Intercytex Group plc
02 September 2009
2 September 2009
Intercytex Group plc
Suspension of trading on AIM
Intercytex Group plc (LSE: ICX) ("Intercytex") today announces temporary
suspension of trading of its shares on AIM. As a result of the ongoing
divestment process, the Company will not be in a position to release interim
financial results before 30 September 2009, and will therefore be suspended from
trading until such results are released.
The Company remains in advanced discussions with a number of parties to divest
certain business assets, and will continue to update shareholders on both the
progress of the strategic review and the potential timing of release of interim
financial results.
Enquiries
For more information, contact:
+--------------------------------------+---------------------------------+
| Intercytex Group plc | |
+--------------------------------------+---------------------------------+
| Nick Higgins, Chief Executive | Tel: 0161 904 4500 |
| Officer | |
+--------------------------------------+---------------------------------+
| Max Herrmann, Chief Financial | |
| Officer | |
+--------------------------------------+---------------------------------+
| | |
+--------------------------------------+---------------------------------+
| Financial Dynamics | |
+--------------------------------------+---------------------------------+
| Jonathan Birt | Tel: 0207 269 7205 |
+--------------------------------------+---------------------------------+
| | |
+--------------------------------------+---------------------------------+
| Piper Jaffray Ltd | |
+--------------------------------------+---------------------------------+
| Will Carnwath | Tel: 0203 142 8700 |
+--------------------------------------+---------------------------------+
Intercytex' shares trade on AIM, a market of the London Stock Exchange, under
the ticker symbol ICX.L.
Additional information on the Company can be found at www.intercytex.com
Statements contained within this press release may contain forward-looking
information or statements with respect to the financial condition, results of
operations and business achievements/performance of Intercytex and certain of
the plans and objectives of management of Intercytex with respect thereto. By
their nature, forward-looking statements involve risks and uncertainties that
may cause actual results to vary from those contained in the forward-looking
statements. In some cases, you can identify such forward-looking statements by
terminology such as 'may', 'will', 'could', 'forecasts', 'expects', 'plans',
'anticipates', 'believes', 'estimates', 'predicts', 'potential', 'continue' or
similar expressions. A number of factors, including the satisfactory progress of
research and development, could cause Intercytex' actual financial condition,
results of operations and business achievements/performance to differ materially
from the estimates made or implied in such forward-looking statements and,
accordingly, reliance should not be placed on such statements. Forward
projections reflect management's best estimates based on information available
at the time of issue and are not a guarantee of future performance. Other than
as required by applicable law, Intercytex does not undertake any obligation to
update or revise any forward-looking information or statements to reflect events
or circumstances after the date of this release. The term "Intercytex" refers to
Intercytex Group plc and its subsidiary undertakings.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SRSILFVEAVILIIA
Intercytex (LSE:ICX)
Historical Stock Chart
From May 2024 to Jun 2024
Intercytex (LSE:ICX)
Historical Stock Chart
From Jun 2023 to Jun 2024